The Federal Trade Commission (FTC) issued warning letters back on January 19 to more than 20 companies – including some direct sellers – to immediately stop making baseless claims regarding their products treating or preventing COVID-19.
Regulation in this area and beyond by the FTC and other regulatory agencies continues to escalate in the early stages of 2022. While trying to ignore these compliance challenges was never a viable option, lack of action now could result in financial ruin for direct sellers of any size.
Click below to learn the complete details regarding the FTC's action against companies making false COVID-19 claims.
